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Sir,
We found Dr van Noord’s preconceptional mitochondrial hypoth-
esis interesting particularly in line with a recent report linking
polymorphisms of two DNA base excision repair genes (XRCC1
and hOGG1) to breast cancer risk in daughters born to older
mothers (Hodgson et al, 2003). Manganese superoxide dismutase
(MnSOD) may impair the mitochondria’s ability to reduce
oxidative stress (Oberley and Oberley, 1997). MnSOD has been
linked to breast cancer (Ambrosone et al, 1999), and may be
another pathway through which older maternal age may function.
Further support for this hypothesis comes from a recent study that
found mitochondrial DNA damage in breast cancer tissue (Richard
et al, 2000).
To test this hypothesis, we analysed the association of parental
age with breast cancer risk using data from the Shanghai Breast
Cancer Study (SBCS), and the results are in shown Table 1. After
adjustment for established breast cancer risk factors and
pregnancy order, we did not find an association between older
maternal or paternal age and premenopausal breast cancer in our
low-risk population. Additional adjustment for paternal age
resulted in a nonsignificantly elevated risk of breast cancer
associated with older maternal age. All perinatal information was
based on maternal report.
Although we collected information on whether the mother had a
threatened miscarriage with the index pregnancy, too few women
reported this adverse event (six case mothers, 13 control mothers)
to provide a stable risk estimate. Other studies may have sufficient
numbers of mothers to investigate this aspect of Dr van Noord’s
hypothesis.
Dr van Noord argued that insulin-like growth factor- I (IGF-1)
might be unlikely to explain the inconsistent findings on birth
weight and breast cancer risk in the literature, since the link
between IGF-I and breast cancer risk has been found primarily in
premenopausal women, while the high birth weight-breast cancer
association has been seen among pre- and postmenopausal
women. A previous report from the SBCS showed that elevated
levels of IGF-I were associated with an increased risk of breast
cancer among all women, but the association was more
pronounced among women diagnosed premenopausally and
among women with a high body mass index or waist-to-hip ratio
(Yu et al, 2001). We found in a large US study that high birth
Table 1 Odds ratios of breast cancer associated with maternal age and paternal age
Cases (n¼288) Controls (n¼350) OR
a (95% CI) OR
b (95% CI)
Maternal age (years)
o25 73 98 1.0 (referent) 1.0 (referent)
25–29 123 127 1.4 (0.8–2.3) 1.6 (0.9–2.7)
30–34 63 77 1.1 (0.6–2.0) 1.5 (0.8–2.9)
X35 29 47 1.1 (0.5–2.2) 1.6 (0.7–3.9)
P trend P¼0.84 P¼0.34
Paternal age (years)
o25 34 41 1.0 (referent) 1.0 (referent)
25–29 96 94 1.4 (0.7–2.8) 1.3 (0.6–2.7)
30–34 88 103 1.3 (0.7–2.7) 1.2 (0.6–2.6)
X35 70 111 0.9 (0.4–1.9) 0.7 (0.3–1.8)
P trend P¼0.13 P¼0.08
aAdjusted for age, income, family history of breast cancer in first-degree relative, history of fibroadenoma, age at menarche,
parity, age at first live birth, and pregnancy order.
bAdjusted for age, income, family history of breast cancer in first-degree
relative, history of fibroadenoma, age at menarche, parity, age at first live birth, pregnancy order, and maternal age or
paternal age.
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www.bjcancer.comweight was associated with an elevated risk among premenopausal
women (OR¼1.7, 95% CI 1.1–2.5), but a nonsignificantly
reduced risk among postmenopausal women (OR¼0.6, 95% CI
0.3–1.1) (Sanderson et al, 1996). Therefore, IGF-I as a potential
explanation for the birth weight-breast cancer relationship cannot
be ruled out.
REFERENCES
Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE,
Marshall JR, Graham S, Laughlin R, Nemoto T, Shields PG (1999)
Manganese superoxide dismutase (MnSOD) genetic polymorphisms,
dietary antioxidants, and risk of breast cancer. Cancer Res 59: 602–606
Hodgson ME, Worley K, Winkel S, Tse CK, Eaton A, Harlan B, Millikan RC
(2003) Maternal age, polymorphisms in two DNA repair genes and breast
cancer in the Carolina Breast Cancer Study. Presented at the Research
Molecular and Genetic Epidemiology of Cancer American Association
for Cancer International Conference, Waikoloa, HI, January, 2003
Oberley TD, Oberley LW (1997) Antioxidant enzyme levels in cancer. Histol
Histopathol 12: 525–535
Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO
(2000) Nuclear and mitochondrial genome instability in human breast
cancer. Cancer Res 60: 4231–4237
Sanderson M, Williams MA, Malone KE, Stanford JL, Emanuel I, White E,
Daling JR (1996) Perinatal factors and risk of breast cancer. Epidemiol-
ogy 7: 34–37
Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HR, Zheng W (2002)
Insulin like growth factors and breast cancer risk in Chinese women.
Cancer Epidemiol Biomark Prev 11: 705–712
Reply 2: Birth weight as a predictor of breast cancer:
a case–control study in Norway
LJ Vatten*,1 and TIL Nilsen
1,2
1Department of Community Medicine and General Practice, Norwegian University of Science and Technology, Medical Research Center, N-7489
Trondheim, Norway;
2The Norwegian Cancer Society, PO Box 5327 Majorstua, N-0304 Oslo, Norway
British Journal of Cancer (2003) 88, 1820–1821. doi:10.1038/sj.bjc.6600979 www.bjcancer.com
& 2003 Cancer Research UK
                
Sir,
We welcome the comments of van Noord concerning the different
results for birth weight and breast cancer risk reported by
ourselves (Vatten et al, 2002) and Sanderson et al (2002). He
suggests that women’s breast cancer risk is influenced by the
preconception viability of their mothers’ oocytes, particularly the
quality of their mitochondria, since mitochondrial quality declines
with age. Therefore, van Noord proposes that maternal age at birth
is positively associated with breast cancer risk, suggesting that we
reanalyse our data to test this hypothesis.
Reliable information on maternal age at birth was available in
the Trondheim data, and hence this analysis is based on 186 breast
cancer cases and 662 age-matched controls. We used conditional
logistic regression to explore the association between the risk of
breast cancer and maternal age at birth, and the estimated odds
ratios are adjusted for age at first birth and parity. As shown in
Table 1, we found no association with breast cancer risk over the
four categories of maternal age at birth.
Although van Noord has proposed an interesting hypothesis, we
found no evidence to support that maternal age at birth is
positively associated with breast cancer risk. In light of our
original findings, that both birth weight and birth length are
positively associated with breast cancer risk, important mechan-
isms linking birth characteristics to breast cancer may be related to
foetal growth. Recent research has shown that both birth weight
and maternal pre-eclampsia are associated with adolescent growth
and maturation (Vatten et al, 2003), and therefore, the intrauterine
environment may initiate a tracking pattern of growth that ranges
throughout childhood and adolescence. Ultimately, this may play a
critical role in the development of breast cancer.
Table 1 Odds ratios (ORs) and 95% confidence intervals (CIs) of breast
cancer associated with maternal age at birth
Variable
Case
patients
Control
subjects OR
ab 95% CI
Maternal age at birth
o25 56 196 1.0 Reference
25–29 60 212 1.0 0.7–1.5
30–34 41 155 1.0 0.6–1.5
X35 29 99 1.0 1.6–1.6
P trend¼0.97
aORs are computed using conditional logistic regression with cases and controls
matched on year of birth.
bORs are adjusted for age at first birth and parity in the
regression model.
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